Skip to main content

Table 4 Multivariate analysis of platelet reactivity in patients under ticagrelor

From: Diabetes mellitus and platelet reactivity in patients under prasugrel or ticagrelor treatment: an observational study

 

Coefficient (SE)

t

95 % CI

Exponentiated coefficient*

p-value

Male gender

0.04 (0.11)

0.15

−0.17 to 0.26

1.04

0.7

Current smoking

−0.19 (0.15)

1.54

−0.48 to 0.11

0.83

0.2

-Insulin-treated diabetes mellitus (vs non-diabetic status)

0.10 (0.18)

0.28

−0.26 to 0.45

1.11

0.6

-Non insulin-treated diabetes mellitus (vs non-diabetic status)

0.08 (0.10)

0.74

−0.11 to 0.27

1.08

0.4

Age

0.001 (0.005)

0.04

−0.008 to 0.01

1.001

0.9

Body mass index

−0.002 (0.01)

0.03

−0.02 to 0.02

0.998

0.9

Creatinine clearance < 60 ml/min

0.20 (0.12)

2.98

−0.03 to 0.43

1.22

0.08

Statin

0.33 (0.19)

2.99

−0.04 to 0.71

1.39

0.08

Proton pump inhibitor

0.07 (0.17)

0.18

−0.26 to 0.41

1.07

0.7

Hypertension

0.006 (0.09)

0.005

−0.17 to 0.18

1.006

0.9

STEMI at admission

−0.12 (0.09)

1.80

−0.29 to 0.05

0.89

0.2

  1. Abbreviations as in Table 2